Related Experiment Video

Updated: Jun 29, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

959

The interplay between autophagy and ferroptosis presents a novel conceptual therapeutic framework for neuroendocrine

Youzhi Wang1, Ning Wu2, Junbo Li1

  • 1Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.

Pharmacological Research
|March 30, 2024
PubMed

Insights

Neuroendocrine prostate cancer (NEPC) can develop from standard antiandrogen therapies. Understanding autophagy and ferroptosis pathways offers potential new targets for NEPC treatment and patient risk stratification.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Prostate cancer (PC) is a leading cause of cancer mortality in American men.
  • Antiandrogen therapies for advanced PC risk inducing neuroendocrine prostate cancer (NEPC).
  • Neuroendocrine differentiation (NED) is a key factor in PC development, influenced by pathways like PI3K/AKT/mTOR, YAP1, and AMPK.

Purpose of the Study:

  • To explore the roles of autophagy and ferroptosis in NEPC development.
  • To identify potential therapeutic targets within these pathways for NEPC.
  • To improve risk stratification and treatment efficacy for NEPC patients.

Main Methods:

  • Review of clinical trials and preclinical investigations on NEPC signaling pathways.
  • Analysis of the involvement of autophagy and ferroptosis in cancer regulation.
  • Investigation of developmental programs related to autophagy and ferroptosis.

Main Results:

  • Autophagy and ferroptosis are pivotal in regulating various cancers.
  • These processes are emerging as potential targets for NEPC regulation.
  • Understanding their dual role in cancer is crucial.

Conclusions:

  • Autophagy and ferroptosis hold promise as therapeutic targets for NEPC.
  • Further research into these pathways can enhance NEPC patient management.
  • Deeper understanding may improve risk stratification and treatment outcomes for NEPC.
Keywords:
Autophagy, ferroptosisNEPC

More Related Videos

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy09:59

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy

Published on: May 3, 2013

17.9K
Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

902

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.5K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K